News summary

Avaí Bio reports peer-reviewed publication on sustained Klotho delivery

Source: Longevity Technology • Published: 29 Oct 2026, 11:31

Summarized by Masters of Longevity from Longevity Technology.

A review links lower Klotho to age-related diseases and describes encapsulation.

Avaí Bio reports peer-reviewed publication on sustained Klotho delivery
Key Takeaways
  • Lower Klotho is linked to kidney, heart, brain, and metabolic disease.
  • Encapsulated cells were shown to secrete Klotho continuously in vitro.
  • Clinical studies have not established dosing, long-term safety, or efficacy.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.